EMEA-001979-PIP01-16 - paediatric investigation plan

Lifitegrast

Key facts

• Active Substance:
  Lifitegrast
• Therapeutic area:
  Ophthalmology
• Decision number:
  P/0263/2016
• PIP number:
  EMEA-001979-PIP01-16
• Pharmaceutical form(s):
  • Eye drops, solution
  • Solution
• Condition(s) / indication(s):
  Treatment of dry eye disease
• Route(s) of administration:
  Ophthalmic use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  05/10/2016

Decision

P/0263/2016: EMA decision of 5 October 2016 on the granting of a product specific waiver for lifitegrast (EMEA-001979-PIP01-16)

AdoptedReference Number: EMA/593398/2016